IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Performance
Performance Report
Kwality Pharmaceuticals IPO listing price is ₹ 44.50, issue price is [●], and currently trading at ₹ 890.35 as on May 30, 2025. Kwality Pharmaceuticals IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Kwality Pharmaceuticals IPO is a Fixed Price listing on BSE SME exchange. The company is based in Amritsar and caters to Pharmaceutical sector. Guiness Corporate Advisors is the merchant banker of Kwality Pharmaceuticals IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on [●].
Kwality Pharmaceuticals IPO offer price is ₹ 45.00 and got listed at ₹ 44.50. Read Kwality Pharmaceuticals IPO details mentioned above.The IPO of Kwality Pharmaceuticals Limited was listed on 18th July 2016. As of today, Kwality Pharmaceuticals IPO is trading at ₹ 890.35, compared to the previous day’s close of ₹ 923.95. Read the report above for detailed IPO performance.
The issue price of Kwality Pharmaceuticals IPO was [●] per equity share.
Kwality Pharmaceuticals IPO was listed at ₹44.50 on the stock exchange on 18th July 2016. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of May 30, 2025, the current market price of Kwality Pharmaceuticals IPO is ₹ 890.35.
The 52-week high for Kwality Pharmaceuticals IPO is [●], while the 52-week low is [●]. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Kwality Pharmaceuticals IPO listed at ₹ 44.50 against the issue price of [●] per equity share, showing a listing day gain/loss of -0.5 (-1.11%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Kwality Pharmaceuticals IPO stock moved from its listing price of ₹ 44.50 to the current price of ₹890.35 per equity share, reflecting a change of 1,900.79% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Kwality Pharmaceuticals IPO issue date of May 30, 2025 and CMP of ₹890.35, the estimated CAGR is approximately 39.99%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Face
Value :
₹ 10
Issue
Price :
[●]
Listing Price :
₹ 44.50
Previous Day Closing
₹ 923.95
Kwality Pharmaceuticals IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Kwality Pharmaceuticals Financial Review Page
Merchant Banker(s) of Kwality Pharmaceuticals IPO: Guiness Corporate Advisors Private Limited
Kwality Pharmaceuticals IPO subscription was 0.00 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Kwality Pharmaceuticals IPO listed at a listing price of 44.50 against the offer price of 45.00.
The current market price of Kwality Pharmaceuticals is 890.35.
Why Us?
